BARINTHUS BIOTHERAPEUTICS PLC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.99 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.83M shares, a 40.65% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 8.13M shares, a 6.39% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 7.65M shares, a 12.30% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 6.81M shares, a 489.10% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.98M shares, a 17.97% decline from fiscal 2024.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.29M shares, a 17.36% increase from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.21M shares, a 113.12% increase from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.91M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 3.99M shares 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | 4.83M shares 10-Q · filed 2026-04-30 | ||||
| 2025-12-31 | 5.98M shares 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | 6.23M shares 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | 7.63M shares 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | 8.13M shares 10-Q · filed 2026-04-30 | ||||
| 2024-12-31 | 7.29M shares 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | 7.34M shares 10-Q · filed 2025-11-07 | ||||
| 2024-06-30 | 7.78M shares 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | 7.65M shares 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | 6.21M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 6.39M shares 10-Q · filed 2024-11-06 | ||||
| 2023-06-30 | 6.78M shares 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | 6.81M shares 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | 2.91M shares 10-K · filed 2024-03-20 | 921.18K shares 10-K · filed 2023-03-24 | |||
| 2022-09-30 | 909.44K shares 10-Q · filed 2023-11-09 | 1.01M shares 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 971.83K shares 10-Q · filed 2023-08-10 | 1.06M shares 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | 1.16M shares 10-Q · filed 2023-05-12 |